Medical Condition

breast carcinoma

Total Trials

14

Recruiting Now

14

Trial Phases

Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for breast carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — breast carcinoma Clinical Trials

How many clinical trials are currently recruiting for breast carcinoma?

ClinicalMetric currently tracks 14 actively recruiting clinical trials for breast carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for breast carcinoma?

breast carcinoma research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a breast carcinoma clinical trial?

Eligibility criteria for breast carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

Phase 3

Top Sponsors

City of Hope Medical Center 2 trials

Alpha Tau Medical LTD. 1 trial

Emory University 1 trial

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 1 trial

Cancer Research Antwerp 1 trial

Recruiting Clinical Trials

NCT06202118

Recruiting

A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.

Alpha Tau Medical LTD.

View Trial →

NCT07764796

Recruiting

Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya

RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study

Fondazione IRCCS Istituto Nazi...

View Trial →

NCT06739655

Recruiting

Preoperative Radiation Therapy and Immediate Breast Reconstruction

Cancer Research Antwerp

View Trial →

NCT06927102

Recruiting

From Exclusion to Inclusion: Analysing Follow-up Discontinuity in Breast Cancer

Basavatarakam Indo American Ca...

View Trial →

NCT03870620

Recruiting

Metastatic Breast Cancer in Austria

Arbeitsgemeinschaft medikament...

View Trial →

NCT07741968

Recruiting

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

City of Hope Medical Center

View Trial →

NCT06144164 Phase 3

Recruiting

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Memorial Sloan Kettering Cance...

View Trial →

NCT04913064

Recruiting

Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer

City of Hope Medical Center

View Trial →

NCT06835426

Recruiting

High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

Algemeen Ziekenhuis Maria Midd...

View Trial →

NCT07067138

Recruiting

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

National Cancer Institute (NCI...

View Trial →

NCT06762496

Recruiting

A New Tool to Promote Patient's Engagement in Their Healthcare Process

European Institute of Oncology

View Trial →

NCT06666192

Recruiting

The Ohio State University (OSU) SCREEN Community Program

Ohio State University Comprehe...

View Trial →

NCT06268665 Phase 2

Recruiting

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

University of California, Davi...

View Trial →

Related Conditions

breast cancer (6) breast cancer stage iv (2) breast neoplasms (2) breast cancer stage i (2) breast cancer stage ii (2) recurrent breast cancer (1) radiomic (1) radiomics (1) breast cancer metastatic (1) breast cancer with bone metastasis (1) breast cancer with metastatic bone disease (1) trastuzumab (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology